This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
TreeHouse Foods (THS) Q4 Earnings Coming Up: What to Expect?
by Zacks Equity Research
TreeHouse Foods' (THS) fourth-quarter results are likely to reflect supply-chain disruptions and the impacts of the recent voluntary product recall. Gains from pricing have been an upside.
What You Need to Know Ahead of Kraft Heinz (KHC) Q4 Earnings
by Zacks Equity Research
Kraft Heinz's (KHC) fourth-quarter results are likely to reflect the adverse impact of inflationary headwinds. Also, rising SG&A costs are concerning.
Things to Consider Ahead of Nu Skin's (NUS) Q4 Earnings
by Zacks Equity Research
Nu Skin's (NUS) fourth-quarter 2023 earnings will likely reflect the adverse impact of macroeconomic challenges like a slowdown in consumer spending. Unfavorable currency translations pose concerns.
Service Corporation (SCI) to Report Q4 Earnings: Factors to Note
by Zacks Equity Research
Service Corporation's (SCI) fourth-quarter 2023 results are likely to reflect softness in its Funeral business. Also, the company is not immune to an inflationary environment.
Hershey (HSY) Q4 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Hershey's (HSY) Q4 results reflect gains from pricing amid lower volumes. The company continues to focus on innovation and efficiency despite market challenges.
Coty (COTY) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Coty (COTY) delivered earnings and revenue surprises of 25% and 3.42%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Hain Celestial (HAIN) Q2 Earnings Beat Estimates, Decline Y/Y
by Zacks Equity Research
Hain Celestial (HAIN) posts mixed results in second-quarter fiscal 2024. The International segment's net sales grew 8.5% year over year in the quarter.
McCormick (MKC) Gains on Innovation & Pricing Amid Cost Woes
by Zacks Equity Research
McCormick's (MKC) strategic focus on pricing, innovation and efficiency underpins its industry leadership and growth despite facing inflation and volume challenges.
Energizer (ENR) Q1 Earnings & Sales Beat Estimates, Dip Y/Y
by Zacks Equity Research
Energizer's (ENR) fiscal first-quarter earnings beat estimates by a couple of cents. Amid challenges, the company is focusing on cost-saving measures and undertaking strategic endeavors.
Kellanova (K) Q4 Earnings Coming Up: Factors to Consider
by Zacks Equity Research
Kellanova's (K) fourth-quarter performance is likely to reflect the adverse impact of rising costs and supply-chain bottlenecks. Unfavorable foreign currency rates are a hurdle.
Flowers Foods' (FLO) Q4 Earnings Coming Up: What to Expect?
by Zacks Equity Research
Flowers Foods' (FLO) fourth-quarter results are likely to reflect gains from pricing and brand strength, while high selling, distribution and administrative expenses might have hurt profits.
Things to Consider Before Hain Celestial's (HAIN) Q2 Earnings
by Zacks Equity Research
Hain Celestial's (HAIN) second-quarter fiscal 2024 earnings are likely to reflect weakness in the North America segment. Focus on brand-building efforts is an upside.
COTY Unveils Partnership With Luxury Fashion Brand Marni
by Zacks Equity Research
COTY's collaboration with Marni, which will be launched in fiscal 2026, aims to bolster its luxury segment with innovative beauty products, reflecting its strategy for growth and market expansion.
Hershey's (HSY) Q4 Earnings Coming Up: What Should You Know?
by Zacks Equity Research
Hershey's (HSY) fourth-quarter results are likely to reflect gains from pricing and brand strength, while high selling, marketing and administrative expenses might have dented the bottom line.
Philip Morris (PM) Q4 Earnings Coming Up: What to Expect?
by Zacks Equity Research
Philip Morris' (PM) fourth-quarter results are likely to reflect strength in smoke-free products and gains from pricing power, though cigarette volumes have been declining year over year.
Estee Lauder (EL) Cuts FY24 Profit View Despite Q2 Earnings Beat
by Zacks Equity Research
Estee Lauder's (EL) second-quarter fiscal 2024 results reflect lower net sales and earnings amid global macroeconomic volatility. Management lowers fiscal 2024 earnings view.
COTY Set to Report Q2 Earnings: Factors to Keep in Mind
by Zacks Equity Research
COTY's second-quarter performance is likely to reflect gains across the Prestige and Consumer Beauty businesses. However, the rising cost of sales is a concern.
Clorox (CLX) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Clorox (CLX) posts solid second-quarter fiscal 2024 results, backed by higher volumes, and gains from pricing actions and cost-saving initiatives.
Tyson Foods (TSN) Q1 Earnings Coming Up: Is a Beat Likely?
by Zacks Equity Research
Tyson Foods' (TSN) first-quarter results are likely to reflect gains from the company's strategic initiatives and solid brands, though high costs are likely to have played a spoilsport.
Will Inter Parfums (IPAR) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Inter Parfums (IPAR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Things to Note Before Columbia Sportswear's (COLM) Q4 Earnings
by Zacks Equity Research
Columbia Sportswear's (COLM) fourth-quarter results are likely to reflect concerns like soft consumer demand due to a challenging operating landscape.
Altria's (MO) Q4 Earnings Coming Up: Factors Worth Noting
by Zacks Equity Research
Altria's (MO) fourth-quarter results are likely to reflect cigarette volume concerns, though strength in pricing and RRPs is likely to have been an upside.
Colgate (CL) Q4 Earnings & Sales Beat Estimates, '24 View Issued
by Zacks Equity Research
Colgate's (CL) Q4 results benefited from strong sales growth, robust organic volume growth and gross and operating margin expansion.
Inter Parfums (IPAR) Q4 Sales Advance on Brand Strength
by Zacks Equity Research
Inter Parfums' (IPAR) U.S.-based operations witness remarkable 13% sales growth in the fourth quarter, primarily driven by Donna Karan/DKNY.
Inter Parfums (IPAR) Upgraded to Buy: Here's Why
by Zacks Equity Research
Inter Parfums (IPAR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).